Study on the Effects of Cranberry Phospholipids Tablets on Urination in Healthy Japanese Adults Randomized, Double-Blind, Placebo-Controlled Trial

What this Trial Is About

Researchers are studying healthy Japanese adults who have concerns about frequent urination during the daytime. The main goal is to find out if taking Cranberry Phospholipids can reduce the number of times participants urinate during the day. The study compares groups taking Cranberry Phospholipids to those taking a placebo to see if there is any difference in urinary frequency. Participants will take two tablets daily containing Cranberry Phospholipids or placebo for eight weeks. The study is randomized, placebo-controlled, double-blind, and parallel-group designed. One group takes tablets with 120 mg of Cranberry Phospholipids per tablet, while the other group takes tablets without the active ingredient. The trial lasts for an eight-week intervention period. During the study, participants will complete questionnaires about overactive bladder symptoms, quality of life related to bladder issues, and urinary frequency. Researchers will monitor changes in urinary frequency using these questionnaires before and after the intervention. Safety is checked by urinalysis and blood tests at the start and end of the study. The primary outcome is the change in daytime urinary frequency after eight weeks of treatment.

Effects of the Consumption of Test Product on Urination in Healthy Japanese Adults